Takeda Pharmaceutical reports Q1 earnings growth with EPS at ¥154 and operating profit up 11.5% year-over-year to ¥358.9B.
Takeda Pharmaceutical reported first-quarter earnings per share of ¥154, up 1.5% year-over-year, though down 11.8% on a constant currency basis. Revenue declined sharply to ¥1.22 trillion due to a one-time accounting adjustment, while operating profit increased 11.5% to ¥358.9 billion versus ¥321.8 billion a year earlier.
The company’s operating margin improved by 0.3 percentage points to 29.4%, while net profit reached ¥242.9 billion. The results reflect ongoing cost management efforts amid currency headwinds and restructuring impacts.
Shares showed limited movement in early trading as investors digested the mixed performance metrics.